Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes

Recently a number of randomized trials have shown that patients with advanced colorectal cancer do not benefit from therapies targeting the epidermal growth factor receptor when their tumors harbor mutations in the KRAS, BRAF and PIK3CA genes. We developed two multiplex assays that simultaneously sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lurkin, Irene, Stoehr, Robert, Hurst, Carolyn D., van Tilborg, Angela A. G., Knowles, Margaret A., Hartmann, Arndt, Zwarthoff, Ellen C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809099/
https://www.ncbi.nlm.nih.gov/pubmed/20098682
http://dx.doi.org/10.1371/journal.pone.0008802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809099/
https://www.ncbi.nlm.nih.gov/pubmed/20098682
http://dx.doi.org/10.1371/journal.pone.0008802

Ejemplares similares